Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis

Biological Psychiatry

Volumn 75, Issue 4, 2014, Pages 284-291

  Deakin, Julia ^a   Lennox, Belinda R ^b   Zandi, Michael S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Autoantibody; encephalitis; encephalopathy; leucine rich glioma inactivated 1 (Lgi1); N methyl D aspartate receptor (NMDAR); paraneoplastic; psychosis; schizophrenia; voltage gated potassium channel complex (VGKC)

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; AUTOANTIBODY; BRAIN PROTEIN; CELL SURFACE PROTEIN; GLYCINE; IMMUNOGLOBULIN; MEMBRANE ANTIGEN; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SYNAPTIC PROTEIN; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CELL ASSAY; CELL SURFACE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; ENCEPHALITIS; HUMAN; HUMORAL IMMUNITY; NEUROIMMUNOLOGY; NEUROPATHOLOGY; NONHUMAN; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODY; ENCEPHALITIS; ENCEPHALOPATHY; LEUCINE-RICH GLIOMA-INACTIVATED 1 (LGI1); N-METHYL-D-ASPARTATE RECEPTOR (NMDAR); PARANEOPLASTIC; PSYCHOSIS; SCHIZOPHRENIA; VOLTAGE-GATED POTASSIUM CHANNEL COMPLEX (VGKC);

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BRAIN DISEASES; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; NERVE TISSUE PROTEINS; PSYCHOTIC DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SYNAPSES;

EID: 84892568180     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.07.018     Document Type: Review

References (98)

1. M.S. Zandi, S.R. Irani, B. Lang, P. Waters, P.B. Jones, and P. McKenna et al. Disease-relevant autoantibodies in first episode schizophrenia J Neurol 258 2011 686 688
2. J. Steiner, M. Walter, W. Glanz, Z. Sarnyai, H.G. Bernstein, and S. Vielhaber et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: Specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis JAMA Psychiatry 70 2013 271 278
3. C. Buckley, J. Oger, L. Clover, E. Tuzun, K. Carpenter, and M. Jackson et al. Potassium channel antibodies in two patients with reversible limbic encephalitis Ann Neurol 50 2001 73 78
4. L. Zuliani, F. Graus, B. Giometto, C. Bien, and A. Vincent Central nervous system neuronal surface antibody associated syndromes: Review and guidelines for recognition J Neurol Neurosurg Psychiatry 83 2012 638 645
5. H. Lehman-Facius Liquoruntersuchungen bei destruktiven Erkrankungen des Nervensystems, besonders bei Schizophrenie Z Ges Neurol Psychiat 158 1937 109 115
6. A.E. Henneberg, S. Horter, and S. Ruffert Increased prevalence of antibrain antibodies in the sera from schizophrenic patients Schizophr Res 14 1994 15 22
7. A.L. Jones, B.J. Mowry, M.P. Pender, and J.M. Greer Immune dysregulation and self-reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol 83 2005 9 17
8. J.B. Brierley, J.A. Corsellis, R. Hierons, and S. Nevin Subacute encephalitis of later adult life, mainly affecting the limbic areas Brain 83 1960 357 368
9. J.A. Corsellis, G.J. Goldberg, and A.R. Norton "Limbic encephalitis" and its association with carcinoma Brain 91 1968 481 496
10. J. Dalmau, and M.R. Rosenfeld Paraneoplastic syndromes of the CNS Lancet Neurol 7 2008 327 340
11. A. Vincent, C. Buckley, J.M. Schott, I. Baker, B.K. Dewar, and N. Detert et al. Potassium channel antibody-associated encephalopathy: A potentially immunotherapy-responsive form of limbic encephalitis Brain 127 2004 701 712
12. S.R. Irani, S. Alexander, P. Waters, K.A. Kleopa, P. Pettingill, and L. Zuliani et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia Brain 133 2010 2734 2748
13. M. Lai, M.G. Huijbers, E. Lancaster, F. Graus, L. Bataller, and R. Balice-Gordon et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: A case series Lancet Neurol 9 2010 776 785
14. J. Dalmau, E. Tuzun, H.Y. Wu, J. Masjuan, J.E. Rossi, and A. Voloschin et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma Ann Neurol 61 2007 25 36
15. J. Dalmau, A.J. Gleichman, E.G. Hughes, J.E. Rossi, X. Peng, and M. Lai et al. Anti-NMDA-receptor encephalitis: Case series and analysis of the effects of antibodies Lancet Neurol 7 2008 1091 1098
16. S.R. Irani, K. Bera, P. Waters, L. Zuliani, S. Maxwell, and M.S. Zandi et al. N-methyl-D-aspartate antibody encephalitis: Temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes Brain 133 2010 1655 1667
17. J. Dalmau, E. Lancaster, E. Martinez-Hernandez, M.R. Rosenfeld, and R. Balice-Gordon Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis Lancet Neurol 10 2011 63 74
18. H. Pruss, C. Finke, M. Holtje, J. Hofmann, C. Klingbeil, and C. Probst et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis Ann Neurol 72 2012 902 911
19. M.J. Titulaer, L. McCracken, I. Gabilondo, T. Armangue, C. Glaser, and T. Iizuka et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study Lancet Neurol 12 2013 157 165
20. A.J. Gleichman, L.A. Spruce, J. Dalmau, S.H. Seeholzer, and D.R. Lynch Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain J Neurosci 32 2012 11082 11094
21. R.W. Paterson, M.S. Zandi, R. Armstrong, A. Vincent, and J.M. Schott Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: Experience from a tertiary referral centre [published online ahead of print June 13] J Neurol Neurosurg Psychiatry 2013
22. G. Mackay, K. Ahmad, J. Stone, C. Sudlow, D. Summers, and R. Knight et al. NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease J Neurol 259 2012 1979 1981
23. M. Lai, E.G. Hughes, X. Peng, L. Zhou, A.J. Gleichman, and H. Shu et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location Ann Neurol 65 2009 424 434
24. E. Lancaster, M. Lai, X. Peng, E. Hughes, R. Constantinescu, and J. Raizer et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: Case series and characterisation of the antigen Lancet Neurol 9 2010 67 76
25. A. Boronat, J.M. Gelfand, N. Gresa-Arribas, H.Y. Jeong, M. Walsh, and K. Roberts et al. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels Ann Neurol 73 2013 120 128
26. R.C. Dale, V. Merheb, S. Pillai, D. Wang, L. Cantrill, and T.K. Murphy et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders Brain 135 2012 3453 3468
27. S.R. Irani, A.W. Michell, B. Lang, P. Pettingill, P. Waters, and M.R. Johnson et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis Ann Neurol 69 2011 892 900
28. T. Brenner, G.J. Sills, Y. Hart, S. Howell, P. Waters, and M.J. Brodie et al. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy Epilepsia 54 2013 1028 1035
29. J.M. Pego-Reigosa, and D.A. Isenberg Psychosis due to systemic lupus erythematosus: Characteristics and long-term outcome of this rare manifestation of the disease Rheumatology (Oxford) 47 2008 1498 1502
30. M. Zandi, F. Catapano, S. Burns, F.C. Hall, K.G. Smith, and D.R. Jayne et al. POI06 Rituximab in neuropsychiatric systemic lupus erythematosus: A retrospective study of the Cambridge experience J Neurol Neurosurg Psychiatry 81 2010 e54
31. M.S. Zandi Advances and challenges in neuropsychiatric systemic lupus erythematosus Adv Clin Neurosci Rehabil 10 2010 8 13
32. E.P. Zorrilla, T.D. Cannon, R.E. Gur, and J. Kessler Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: Markers of vulnerability or disease? Biol Psychiatry 40 1996 825 833
33. E. Bonfa, S.J. Golombek, L.D. Kaufman, S. Skelly, H. Weissbach, and N. Brot et al. Association between lupus psychosis and anti-ribosomal P protein antibodies N Engl J Med 317 1987 265 271
34. A. Katzav, I. Solodeev, O. Brodsky, J. Chapman, C.G. Pick, and M. Blank et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system Arthritis Rheum 56 2007 938 948
35. J.G. Hanly, M.B. Urowitz, L. Su, S.C. Bae, C. Gordon, and A. Clarke et al. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus Ann Rheum Dis 70 2011 1726 1732
36. S. Matus, P.V. Burgos, M. Bravo-Zehnder, R. Kraft, O.H. Porras, and P. Farias et al. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis J Exp Med 204 2007 3221 3234
37. L.A. DeGiorgio, K.N. Konstantinov, S.C. Lee, J.A. Hardin, B.T. Volpe, and B. Diamond A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus Nat Med 7 2001 1189 1193
38. L. Lapteva, M. Nowak, C.H. Yarboro, K. Takada, T. Roebuck-Spencer, and T. Weickert et al. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus Arthritis Rheum 54 2006 2505 2514
39. R.C. Dale, K. Yin, A. Ding, V. Merheb, S. Varadkhar, and D. McKay et al. Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies Dev Med Child Neurol 53 2011 522 528
40. E. Littleton, M. Dreger, J. Palace, and A. Vincent Immunocapture and identification of cell membrane protein antigenic targets of serum autoantibodies Mol Cell Proteomics 8 2009 1688 1696
41. R.C. Dale, S.R. Irani, F. Brilot, S. Pillai, R. Webster, and D. Gill et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica Ann Neurol 66 2009 704 709
42. J. Rhoads, H. Guirgis, C. McKnight, and A.M. Duchemin Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia Schizophr Res 129 2011 213 214
43. J.C. Masdeu, A. Gonzalez-Pinto, C. Matute, S. Ruiz De Azua, A. Palomino, and J. De Leon et al. Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia Am J Psychiatry 169 2012 1120 1121
44. M.R. Chapman, and H.E. Vause Anti-NMDA receptor encephalitis: Diagnosis, psychiatric presentation, and treatment Am J Psychiatry 168 2011 245 251
45. A. Consoli, K. Ronen, I. An-Gourfinkel, M. Barbeau, D. Marra, and N. Costedoat-Chalumeau et al. Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17-year-old girl: Case report Child Adolesc Psychiatry Ment Health 5 2011 15
46. Y.L. Kuo, H.F. Tsai, M.C. Lai, C.H. Lin, and Y.K. Yang Anti-NMDA receptor encephalitis with the initial presentation of psychotic mania J Clin Neurosci 19 2012 896 898
47. A. McCarthy, J. Dineen, P. McKenna, M. Keogan, J. Sheehan, and T. Lynch et al. Anti-NMDA receptor encephalitis with associated catatonia during pregnancy J Neurol 259 2012 2632 2635
48. D. Stanischewski, A. Borchert, M. Marziniak, V. Arolt, and F. Kastner Anti-NMDA receptor encephalitis: An important differential diagnosis of catatonia in young psychiatric patients [German] Nervenarzt 84 2013 856 859
49. M. Fousse, C. Becker, K. Fassbender, W. Reith, H. Korner, and M. Alexandrou et al. First occurrence of an organic manic schizophreniform syndrome followed by catatonia induced by anti-NMDA-receptor encephalitis [German] Fortschr Neurol Psychiatr 81 2013 206 209
50. S.A. Ryan, D.J. Costello, E.M. Cassidy, G. Brown, H.J. Harrington, and S. Markx Anti-NMDA receptor encephalitis: A cause of acute psychosis and catatonia J Psychiatr Pract 19 2013 157 161
51. C. Creten, S. van der Zwaan, R.J. Blankespoor, A. Maatkamp, J. Nicolai, and J. van Os et al. Late onset autism and anti-NMDA-receptor encephalitis Lancet 378 2011 98
52. D. Dhossche, M. Fink, E. Shorter, and L.E. Wachtel Anti-NMDA receptor encephalitis versus pediatric catatonia Am J Psychiatry 168 2011 749 750 author reply 750
53. F. Dickerson, C. Stallings, C. Vaughan, A. Origoni, S. Khushalani, and R. Yolken Antibodies to the glutamate receptor in mania Bipolar Disord 14 2012 547 553
54. L. Brain, E.H. Jellinek, and K. Ball Hashimoto's disease and encephalopathy Lancet 2 1966 512 514
55. S. Lebon, C. Mayor-Dubois, I. Popea, C. Poloni, N. Selvadoray, and A. Gumy et al. Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis mimicking a primary psychiatric disorder in an adolescent J Child Neurol 27 2012 1607 1610
56. U.D. Parthasarathi, T. Harrower, M. Tempest, J.R. Hodges, C. Walsh, and P.J. McKenna et al. Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy. Case report Br J Psychiatry 189 2006 182 183
57. K.J. Somers, V.A. Lennon, J.R. Rundell, S.J. Pittock, D.A. Drubach, and M.R. Trenerry et al. Psychiatric manifestations of voltage-gated potassium-channel complex autoimmunity J Neuropsychiatry Clin Neurosci 23 2011 425 433
58. N. Mas, A. Saiz, M.I. Leite, P. Waters, M. Baron, and D. Castano et al. Antiglycine-receptor encephalomyelitis with rigidity J Neurol Neurosurg Psychiatry 82 2010 1399 1401
59. J.G. Knight Dopamine-receptor-stimulating autoantibodies: A possible cause of schizophrenia Lancet 2 1982 1073 1076
60. E.D. Luby, B.D. Cohen, G. Rosenbaum, J.S. Gottlieb, and R. Kelley Study of a new schizophrenomimetic drug; sernyl AMA Arch Neurol Psychiatry 81 1959 363 369
61. D.C. Javitt, and S.R. Zukin Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 148 1991 1301 1308
62. J.T. Coyle NMDA receptor and schizophrenia: A brief history Schizophr Bull 38 2012 920 926
63. J.W. Olney, and N.B. Farber Glutamate receptor dysfunction and schizophrenia Arch Gen Psychiatry 52 1995 998 1007
64. A.R. Mohn, R.R. Gainetdinov, M.G. Caron, and B.H. Koller Mice with reduced NMDA receptor expression display behaviors related to schizophrenia Cell 98 1999 427 436
65. D.C. Javitt Glutamate and schizophrenia: Phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions Int Rev Neurobiol 78 2007 69 108
66. K.E. Stephan, K.J. Friston, and C.D. Frith Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring Schizophr Bull 35 2009 509 527
67. J.E. Belforte, V. Zsiros, E.R. Sklar, Z. Jiang, G. Yu, and Y. Li et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes Nat Neurosci 13 2010 76 83
68. G. Kirov, A.J. Pocklington, P. Holmans, D. Ivanov, M. Ikeda, and D. Ruderfer et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia Mol Psychiatry 17 2012 142 153
69. A.E. Timms, M.O. Dorschner, J. Wechsler, K.Y. Choi, R. Kirkwood, and S. Girirajan et al. Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families JAMA Psychiatry 70 2013 582 590
70. L.S. Pilowsky, R.A. Bressan, J.M. Stone, K. Erlandsson, R.S. Mulligan, and J.H. Krystal et al. First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients Mol Psychiatry 11 2006 118 119
71. H. Won, H.R. Lee, H.Y. Gee, W. Mah, J.I. Kim, and J. Lee et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function Nature 486 2012 261 265
72. S.J. Huffaker, J. Chen, K.K. Nicodemus, F. Sambataro, F. Yang, and V. Mattay et al. A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia Nat Med 15 2009 509 518
73. Y. Fukata, K.L. Lovero, T. Iwanaga, A. Watanabe, N. Yokoi, and K. Tabuchi et al. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy Proc Natl Acad Sci U S A 107 2010 3799 3804
74. S.F. Berkovic, P. Izzillo, J.M. McMahon, L.A. Harkin, A.M. McIntosh, and H.A. Phillips et al. LGI1 mutations in temporal lobe epilepsies Neurology 62 2004 1115 1119
75. R. Ottman, M.R. Winawer, S. Kalachikov, C. Barker-Cummings, T.C. Gilliam, and T.A. Pedley et al. LGI1 mutations in autosomal dominant partial epilepsy with auditory features Neurology 62 2004 1120 1126
76. E.G. Hughes, X. Peng, A.J. Gleichman, M. Lai, L. Zhou, and R. Tsou et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis J Neurosci 30 2010 5866 5875
77. M. Manto, J. Dalmau, A. Didelot, V. Rogemond, and J. Honnorat Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies J Neurol 258 2011 27 33
78. T. Lalic, P. Pettingill, A. Vincent, and M. Capogna Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission Epilepsia 52 2011 121 131
79. L. Mikasova, P. De Rossi, D. Bouchet, F. Georges, V. Rogemond, and A. Didelot et al. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis Brain 135 2012 1606 1621
80. P.J. Harrison The neuropathology of schizophrenia. A critical review of the data and their interpretation Brain 122 1999 593 624
81. L.A. Glantz, and D.A. Lewis Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia Arch Gen Psychiatry 57 2000 65 73
82. C.G. Bien, A. Vincent, M.H. Barnett, A.J. Becker, I. Blumcke, and F. Graus et al. Immunopathology of autoantibody-associated encephalitides: Clues for pathogenesis Brain 135 2012 1622 1638
83. B.R. Lennox, and G.G. Lennox Mind and movement: the neuropsychiatry of movement disorders J Neurol Neurosurg Psychiatry 72 suppl 1 2002 I28 I31
84. N.N. Boutros, C. Arfken, S. Galderisi, J. Warrick, G. Pratt, and W. Iacono The status of spectral EEG abnormality as a diagnostic test for schizophrenia Schizophr Res 99 2008 225 237
85. J. Zanelli, A. Reichenberg, K. Morgan, P. Fearon, E. Kravariti, and P. Dazzan et al. Specific and generalized neuropsychological deficits: A comparison of patients with various first-episode psychosis presentations Am J Psychiatry 167 2010 78 85
86. S. Cohrs Sleep disturbances in patients with schizophrenia: Impact and effect of antipsychotics CNS Drugs 22 2008 939 962
87. D. Hedges, K. Jeppson, and P. Whitehead Antipsychotic medication and seizures: A review Drugs Today (Barc) 39 2003 551 557
88. J. Granerod, H.E. Ambrose, N.W. Davies, J.P. Clewley, A.L. Walsh, and D. Morgan et al. Causes of encephalitis and differences in their clinical presentations in England: A multicentre, population-based prospective study Lancet Infect Dis 10 2010 835 844
89. K.L. Davison, N.S. Crowcroft, M.E. Ramsay, D.W. Brown, and N.J. Andrews Viral encephalitis in England, 1989-1998: What did we miss? Emerg Infect Dis 9 2003 234 240
90. F. Cheng, J.B. Kirkbride, B.R. Lennox, J. Perez, K. Masson, and K. Lawrence et al. Administrative incidence of psychosis assessed in an early intervention service in England: First epidemiological evidence from a diverse, rural and urban setting Psychol Med 41 2011 949 958
91. M.S. Gable, H. Sheriff, J. Dalmau, D.H. Tilley, and C.A. Glaser The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project Clin Infect Dis 54 2012 899 904
92. M.E. Benros, P.B. Mortensen, and W.W. Eaton Autoimmune diseases and infections as risk factors for schizophrenia Ann N Y Acad Sci 1262 2012 56 66
93. P. Albrecht, E.F. Torrey, E. Boone, J.T. Hicks, and N. Daniel Raised cytomegalovirus-antibody level in cerebrospinal fluid of schizophrenic patients Lancet 2 1980 769 772
94. A.D. Borglum, D. Demontis, J. Grove, J. Pallesen, M.V. Hollegaard, and C.B. Pedersen et al. Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci [published online ahead of print January 29] Mol Psychiatry. 2013
95. M.S. Gable, S. Gavali, A. Radner, D.H. Tilley, B. Lee, and L. Dyner et al. Anti-NMDA receptor encephalitis: Report of ten cases and comparison with viral encephalitis Eur J Clin Microbiol Infect Dis 28 2009 1421 1429
96. L.S. Teh, D.G. Doherty, and B.D. Williams HLA-DRB genes and antiribosomal P antibodies in systemic lupus erythematosus Br J Rheumatol 33 1994 1125 1126
97. H. Verhelst, P. Verloo, K. Dhondt, B. De Paepe, B. Menten, and J. Dalmau et al. Anti-NMDA-receptor encephalitis in a 3 year old patient with chromosome 6p21.32 microdeletion including the HLA cluster Eur J Paediatr Neurol 15 2011 163 166
98. S.R. Irani, P. Pettingill, K.A. Kleopa, N. Schiza, P. Waters, and C. Mazia et al. Morvan syndrome: Clinical and serological observations in 29 cases Ann Neurol 72 2012 241 255